Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

271 ARTÍCULOS , VIENDO DEL 196 AL 210

Epigenetic biomarkers in Alzheimer's disease: Diagnostic and prognostic relevance

Behl T, Kyada A, Roopashree R, Nathiya D, Arya R, Kumar MR, Khalid M, Gulati M, Sachdeva M, Fareed M, Patra PK, Agrawal A, Wal P, Gasmi A.

Ageing Res Rev. 2024 Dec;102:102556. doi: 10.1016/j.arr.2024.102556. Epub 2024 Oct 28.

Exploring easily accessible neurophysiological biomarkers for predicting Alzheimer's disease progression: a systematic review

Costanzo M, Cutrona C, Leodori G, Malimpensa L, D'antonio F, Conte A, Belvisi D.

Alzheimers Res Ther. 2024 Nov 4;16(1):244. doi: 10.1186/s13195-024-01607-4.

Pharmacodynamic effects of semorinemab on plasma and CSF biomarkers of Alzheimer's disease pathophysiology

Schauer SP, Toth B, Lee J, Honigberg LA, Ramakrishnan V, Jiang J, Kollmorgen G, Bayfield A, Wild N, Hoffman J, Ceniceros R, Dolton M, Bohórquez SMS, Hoogenraad CC, Wildsmith KR, Teng E, Monteiro C, Anania V, Yeh FL.

Alzheimers Dement. 2024 Dec;20(12):8855-8866. doi: 10.1002/alz.14346. Epub 2024 Nov 8.

Alzheimer's disease: part 2 - the present

Nitrini R.

Arq Neuropsiquiatr. 2024 Jun;82(6):1-9. doi: 10.1055/s-0044-1791755. Epub 2024 Nov 11.

Cerebrovascular markers of WMH and infarcts in ADNI: A historical perspective and future directions

Maillard P, Fletcher E, Carmichael O, Schwarz C, Seiler S, DeCarli C; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2024 Dec;20(12):8953-8968. doi: 10.1002/alz.14358. Epub 2024 Nov 13.

Agreement between Cerebrospinal Fluid Biomarkers, Brain 18-Fluorodeoxyglucose PET, and Clinical Diagnosis in Older Adults with Cognitive Impairment

Alberto J MA, Karen G LD, Rodrigo HR, Juan de D RC, Sara G YC, Sara G AN.

Rev Invest Clin. 2024;76(5):230-237. doi: 10.24875/RIC.24000161.

Advancements and challenges in mouse models of Alzheimer's disease

Qian Z, Li Y, Ye K.

Trends Mol Med. 2024 Dec;30(12):1152-1164. doi: 10.1016/j.molmed.2024.10.010. Epub 2024 Nov 14.

Comparative neurofilament light chain trajectories in CSF and plasma in autosomal dominant Alzheimer's disease

Hofmann A, Häsler LM, Lambert M, Kaeser SA, Gräber-Sultan S, Obermüller U, Kuder-Buletta E, la Fougere C, Laske C, Vöglein J, Levin J, Fox NC, Ryan NS, Zetterberg H, Llibre-Guerra JJ, Perrin RJ, Ibanez L, Schofield PR, Brooks WS, Day GS, Farlow MR, Allegri RF, Chrem Mendez P, Ikeuchi T, Kasuga K, Lee JH, Roh JH, Mori H, Lopera F, Bateman RJ, McDade E, Gordon BA, Chhatwal JP, Jucker M, Schultz SA; Dominantly Inherited Alzheimer Network.

Nat Commun. 2024 Nov 18;15(1):9982. doi: 10.1038/s41467-024-52937-8.

Exploring the Therapeutic Potential of Noncoding RNAs in Alzheimer's Disease

Tripathi S, Sharma Y, Kumar D.

Protein Pept Lett. 2024;31(11):862-883. doi: 10.2174/0109298665335550241011080252.

Acoustic Speech Analysis in Alzheimer's Disease: A Systematic Review and Meta-Analysis

Saeedi S, Hetjens S, Grimm MOW, Barsties V Latoszek B.

J Prev Alzheimers Dis. 2024;11(6):1789-1797. doi: 10.14283/jpad.2024.132.

Blood Cathepsins on the Risk of Alzheimer's Disease and Related Pathological Biomarkers: Results from Observational Cohort and Mendelian Randomization Study

Qian XH, Ding GY, Chen SY, Liu XL, Zhang M, Tang HD.

J Prev Alzheimers Dis. 2024;11(6):1834-1842. doi: 10.14283/jpad.2024.107.

Counseling and disclosure practices in predictive Alzheimer's disease diagnostics: A scoping review

Perry J, Radenbach K, Geschke K, Rostamzadeh A.

Alzheimers Dement. 2024 Dec;20(12):8910-8936. doi: 10.1002/alz.14365. Epub 2024 Nov 19.

Public-Private Partnerships for Neuropsychiatric Drug Development: A Perspective

Potter WZ.

Adv Neurobiol. 2024;40:67-85. doi: 10.1007/978-3-031-69491-2_3.

Centiloid recommendations for clinical context-of-use from the AMYPAD consortium

Collij LE, Bollack A, La Joie R, Shekari M, Bullich S, Roé-Vellvé N, Koglin N, Jovalekic A, Garciá DV, Drzezga A, Garibotto V, Stephens AW, Battle M, Buckley C, Barkhof F, Farrar G, Gispert JD; AMYPAD consortium.

Alzheimers Dement. 2024 Dec;20(12):9037-9048. doi: 10.1002/alz.14336. Epub 2024 Nov 20.

The early diagnosis of Alzheimer's disease: Blood-based panel biomarker discovery by proteomics and metabolomics

Dong Y, Song X, Wang X, Wang S, He Z.

CNS Neurosci Ther. 2024 Nov;30(11):e70060. doi: 10.1111/cns.70060.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias